Dual-Action GLP-1/GIP
Mounjaro (Tirzepatide)
Shown in clinical studies to support weight loss when prescribed appropriately. Acts on appetite regulation and metabolic pathways involved in satiety and glucose control. Prescription treatment is assessed and initiated following an online medical consultation. Up to 22% body weight reduction in trials.
Learn About Mounjaro